Search results
Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know
Zacks via Yahoo News· 1 week agoBristol Myers (BMY) has received quite a bit of attention from Zacks.com users lately. Therefore, it...
Biden administration touts lower costs for 64 prescription drugs
The Hill via Yahoo News· 1 week agoThe Biden administration on Wednesday announced some Medicare beneficiaries will save money on 64...
Bristol Myers Squibb (BMY) Stock Declines While Market Improves: Some Information for Investors
Zacks via Yahoo News· 1 week agoBristol Myers Squibb (BMY) ended the recent trading session at $42.19, demonstrating a -0.09% swing...
Bristol Myers' (BMY) Krazati Gets FDA Nod for Colorectal Cancer
Zacks via Yahoo News· 1 week agoBristol Myers (BMY) wins FDA approval for Krazati, in combination with Erbitux, as a targeted...
The Opaque Industry Secretly Inflating Prices for Prescription Drugs
The New York Times via Yahoo News· 2 weeks agoAmericans are paying too much for prescription drugs. It is a common, long-standing complaint. And...
Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know
Zacks via Yahoo News· 2 weeks agoBristol Myers Squibb (BMY) closed the most recent trading day at $40.81, moving -0.39% from the...
How AI Is Revolutionizing Drug Development
The New York Times via Yahoo News· 2 weeks agoMONROVIA, Calif. — The laboratory at Terray Therapeutics is a symphony of miniaturized automation. Robots whir, shuttling tiny tubes of fluids to their...
Bristol Myers Squibb (BMY) Beats Stock Market Upswing: What Investors Need to Know
Zacks via Yahoo News· 3 weeks agoBristol Myers Squibb (BMY) ended the recent trading session at $43.02, demonstrating a +1.06% swing...
Geron (GERN) Wins FDA Approval for Blood Cancer Drug, Stock Up
Zacks via Yahoo News· 3 weeks agoGeron's (GERN) shares rise on approval of its first drug. The FDA approves imetelstat for the...
Why Is Prothena (PRTA) Down 1.5% Since Last Earnings Report?
Zacks via Yahoo News· 4 weeks agoA month has gone by since the last earnings report for Prothena (PRTA). Shares have lost about 1.5%...